Construction of in vitro patient-derived tumor models to evaluate anticancer agents and cancer immunotherapy

An in vitro assay system using patient-derived tumor models represents a promising preclinical cancer model that replicates the disease better than traditional cell culture models. Patient-derived tumor organoid (PDO) and patient-derived tumor xenograft (PDX) models have been previously established...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Nobuhiko, Higa, Arisa, Hiyama, Gen, Tamura, Hirosumi, Hoshi, Hirotaka, Dobashi, Yuu, Katahira, Kiyoaki, Ishihara, Hiroya, Takagi, Kosuke, Goda, Kazuhito, Okabe, Naoyuki, Muto, Satoshi, Suzuki, Hiroyuki, Shimomura, Kenju, Watanabe, Shinya, Takagi, Motoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020396/
https://www.ncbi.nlm.nih.gov/pubmed/33841567
http://dx.doi.org/10.3892/ol.2021.12667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020396/
https://www.ncbi.nlm.nih.gov/pubmed/33841567
http://dx.doi.org/10.3892/ol.2021.12667

Ejemplares similares